Related Experiment Videos
Summary
Temazepam, a new benzodiazepine, effectively reduces nighttime awakenings and increases sleep duration for insomnia patients. It shows no tolerance or rebound insomnia, making it a suitable hypnotic medication.
Area of Science:
- Pharmacology
- Sleep Medicine
Background:
- Temazepam is a 1,4-benzodiazepine approved for insomnia treatment.
- It is recommended at 30 mg for adults and 15 mg for geriatric/debilitated patients.
Purpose of the Study:
- To evaluate the efficacy and safety of temazepam for insomnia.
- To compare temazepam's pharmacokinetic profile with flurazepam.
Main Methods:
- Conducted eight sleep laboratory and 21 clinical studies.
- Investigated tolerance, metabolism, and carry-over effects.
Main Results:
- Temazepam reduces nighttime awakenings and increases sleep duration.
- No consistent evidence of reduced sleep latency was found.
- No tolerance or rebound insomnia observed in a 35-night study.
Conclusions:
- Temazepam is an effective hypnotic for reducing most insomnia symptoms.
- It has no long-acting metabolites and does not impair waking function.